Subramoni S, Bin Mohammad Muzaki M, Booth S, Kjelleberg S, Rice S
Front Cell Infect Microbiol. 2021; 11:646991.
PMID: 33869078
PMC: 8044998.
DOI: 10.3389/fcimb.2021.646991.
Poudyal B, Sauer K
Antimicrob Agents Chemother. 2017; 62(2).
PMID: 29180529
PMC: 5786766.
DOI: 10.1128/AAC.01981-17.
Kalayci S, Demirci S, Sahin F
World J Microbiol Biotechnol. 2013; 30(2):407-11.
PMID: 23933806
DOI: 10.1007/s11274-013-1456-4.
Robertson G, Doyle T, Du Q, Duncan L, Mdluli K, Lynch A
J Bacteriol. 2007; 189(19):6870-81.
PMID: 17644596
PMC: 2045200.
DOI: 10.1128/JB.00805-07.
Grkovic S, Brown M, Skurray R
Microbiol Mol Biol Rev. 2002; 66(4):671-701, table of contents.
PMID: 12456787
PMC: 134658.
DOI: 10.1128/MMBR.66.4.671-701.2002.
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.
Tacconelli E, Tumbarello M, Bertagnolio S, Citton R, Spanu T, Fadda G
Emerg Infect Dis. 2002; 8(2):220-1.
PMID: 11897080
PMC: 2732442.
DOI: 10.3201/eid0802.010121.
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Dubois V, Arpin C, Melon M, Melon B, Andre C, Frigo C
J Clin Microbiol. 2001; 39(6):2072-8.
PMID: 11376037
PMC: 88091.
DOI: 10.1128/JCM.39.6.2072-2078.2001.
Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
de Kievit T, Parkins M, GILLIS R, Srikumar R, Ceri H, Poole K
Antimicrob Agents Chemother. 2001; 45(6):1761-70.
PMID: 11353623
PMC: 90543.
DOI: 10.1128/AAC.45.6.1761-1770.2001.
A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.
Brooun A, Liu S, Lewis K
Antimicrob Agents Chemother. 2000; 44(3):640-6.
PMID: 10681331
PMC: 89739.
DOI: 10.1128/AAC.44.3.640-646.2000.
Efflux pumps involved in toluene tolerance in Pseudomonas putida DOT-T1E.
Ramos J, Duque E, Godoy P, Segura A
J Bacteriol. 1998; 180(13):3323-9.
PMID: 9642183
PMC: 107285.
DOI: 10.1128/JB.180.13.3323-3329.1998.
Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa.
Wong K, Poole K, Gotoh N, Hancock R
Antimicrob Agents Chemother. 1997; 41(9):2009-12.
PMID: 9303403
PMC: 164054.
DOI: 10.1128/AAC.41.9.2009.
Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.
Tout N, Lam J
Clin Diagn Lab Immunol. 1997; 4(2):147-55.
PMID: 9067648
PMC: 170494.
DOI: 10.1128/cdli.4.2.147-155.1997.
Proton-dependent multidrug efflux systems.
Paulsen I, Brown M, Skurray R
Microbiol Rev. 1996; 60(4):575-608.
PMID: 8987357
PMC: 239457.
DOI: 10.1128/mr.60.4.575-608.1996.
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression.
Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs D, Bianco N
Antimicrob Agents Chemother. 1996; 40(9):2021-8.
PMID: 8878574
PMC: 163466.
DOI: 10.1128/AAC.40.9.2021.
Causes and problems of nonresponse or poor response to drugs.
Salva Lacombe P, Garcia Vicente J, Costa Pages J, Lucio Morselli P
Drugs. 1996; 51(4):552-70.
PMID: 8706594
DOI: 10.2165/00003495-199651040-00004.
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.
Li X, Nikaido H, Poole K
Antimicrob Agents Chemother. 1995; 39(9):1948-53.
PMID: 8540696
PMC: 162861.
DOI: 10.1128/AAC.39.9.1948.
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Rains C, Bryson H, Peters D
Drugs. 1995; 49(4):577-617.
PMID: 7789291
DOI: 10.2165/00003495-199549040-00008.
